IP Library Granted Patent US 11,634,763
Granted Patent B2
US 11,634,763 · App. 16/902,301 · Granted Apr 25, 2023

Enzyme method

Inventors: Ruth Moysey (Oxford, GB); Andrew John Heron (Oxford, GB)
Assignee: Oxford Nanopore Technologies PLC
C12Q1/6869C12Q2521/513C12Q2565/631
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,634,763
App. No.
16/902,301
Granted
Apr 25, 2023
Kind
B2
Abstract

The invention relates to a new method of characterizing a target polynucleotide. The method uses a pore and a Hel308 helicase or amolecular motor which is capable of binding to the target polynucleotide at an internal nucleotide. The helicase or molecular motor controls the movement of the target polynucleotide through the pore.

Claims (23)

1. A method of characterising a target polynucleotide, comprising:

(a) contacting the target polynucleotide with a transmembrane pore under an applied voltage field such that a portion of the target polynucleotide is captured by the transmembrane pore, wherein the pore is present in a membrane;

(b) contacting the target polynucleotide with a Hel308 helicase on the cis side of the membrane such that the helicase binds to the target polynucleotide, thereby controlling the movement of the target polynucleotide through the transmembrane pore against the applied voltage field from the trans side of the membrane to the cis side of the membrane; and

(c) measuring one or more characteristics of the target polynucleotide as the target polynucleotide moves through the transmembrane pore, thereby characterising the target polynucleotide.

2. The method according to claim 1 , wherein the one or more characteristics are selected from (i) the length of the target polynucleotide, (ii) the identity of the target polynucleotide, (iii) the sequence of the target polynucleotide, (iv) the secondary structure of the target polynucleotide and (v) whether or not the target polynucleotide is modified.

3. The method according to claim 2 , wherein the target polynucleotide is modified by methylation, by oxidation, by damage, with one or more proteins, or with one or more labels, tags, or spacers.

4. The method according to claim 1 , wherein at least a portion of the target polynucleotide is double stranded.

5. The method according to claim 1 , wherein the transmembrane pore is a protein pore.

6. The method according to claim 5 , wherein the transmembrane protein pore is selected from the group consisting of: .alpha.-hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP) and WZA.

7. The method according to claim 1 , wherein the Hel308 helicase comprises the amino acid motif Q-X 1 -X 2 -G-R-A-G-R (SEQ ID NO: 8), wherein X 1 is C, M or L and X 2 is any amino acid residue.

8. The method according to claim 7 , wherein X 2 is A, F, M, C, V, L, I, S, T or P.

9. The method according to claim 1 , wherein the Hel308 helicase binds to the target polynucleotide at an internal nucleotide.

10. The method according to claim 1 , wherein the one or more characteristics of the target polynucleotide are measured by electrical measurement and/or optical measurement.

11. The method according to claim 10 , wherein the electrical measurement is a current measurement, an impedance measurement, a tunnelling measurement, or a field effect transistor (FET) measurement.

12. The method according to claim 1 , wherein at least a portion of the polynucleotide is double stranded.

13. The method according to claim 1 , wherein, prior to the movement of the target polynucleotide through the transmembrane pore from the trans side of the membrane to the cis side of the membrane, the target polynucleotide moves from the cis side of the membrane to the trans side of the membrane.

14. The method according to claim 13 , wherein the portion of the target polynucleotide that is captured by a transmembrane pore is the 3′ end of the target polynucleotide.

15. The method according to claim 1 , wherein the portion of the target polynucleotide that is captured by a transmembrane pore is the 5′ end of the target polynucleotide.

16. The method according to claim 1 , wherein the target polynucleotide is partially translocated through the pore in (a).

17. The method according to claim 1 , wherein method is carried out using a salt concentration of at least 0.3 M or at least 1.0 M and the salt is optionally KCl.

18. The method according to claim 1 , wherein an initial helicase controls the movement of the target polynucleotide into the pore in (a).

19. The method according to claim 18 , wherein the Hel308 helicase of (a) binds to an internal polynucleotide of the target polynucleotide at a location on the polynucleotide different than the initial helicase.

20. The method according to claim 1 , wherein the transmembrane pore is a solid state pore.

Assignments (2)
CHANGE OF NAME Recorded Jan 14, 2022
From: OXFORD NANOPORE TECHNOLOGIES LIMITED
To: OXFORD NANOPORE TECHNOLOGIES PLC
Reel/Frame 058737/0664 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2020
From: MOYSEY, RUTH; HERON, ANDREW JOHN
To: OXFORD NANOPORE TECHNOLOGIES LTD.
Reel/Frame 052949/0641 →
Continuity (5)
Continuation 15674653 · Aug 11, 2017
Continuation 14351038
Provisional Application 61599244 · Feb 15, 2012
Provisional Application 61549998 · Oct 21, 2011
Related Publication 20210172011A1 · Jun 10, 2021
Cited By (4)
US 12,252,717 US 12,258,591 US 12,416,625 US 12,503,729